Transfusion Associated AIDS

1982, Possible transfusion-associated acquired immune deficiency syndrome–California, MMWR, 31, 652 Ammann, 1983, Acquired immunodeficiency in an infant: possible transmission by means of blood products, Lancet, 1, 956, 10.1016/S0140-6736(83)92082-2 Curran, 1984, Acquired immunodeficiency syndrome (AIDS) associated with transfusions, New Engl J Med, 310, 69, 10.1056/NEJM198401123100201 Curran, 1984, The acquired immunodeficiency syndrome associated with transfusions: the evolving perspective, Ann Intern Med, 100, 298, 10.7326/0003-4819-100-2-298 Schiffer, 1982, Platelet transfusion from single donors, Sounding Board, 307, 245 Berkman, 1984, Infectious complications of blood transfusions, Semin Oncol, 11, 68 Drew, 1981, Prevalence of cytomegalovirus infection in homosexual men, J Infect Dis, 143, 188, 10.1093/infdis/143.2.188 Sarngadharan, 1984, Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS, Science, 224, 506, 10.1126/science.6324345 Gallo, 1984, Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS, Science, 224, 500, 10.1126/science.6200936 Schüpbach, 1984, Serological analysis of a subgroup of human T-lymphotropic retroviruses (HTLV-III) associated with AIDS, Science, 224, 503, 10.1126/science.6200937 Popovic, 1984, Detection, isolation, and continuous production of cytopathoic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS, Science, 224, 497, 10.1126/science.6200935 Barre-Sinoussi, 1983, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS), Science, 220, 868, 10.1126/science.6189183 Levy, 1984, Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS, Science, 225, 840, 10.1126/science.6206563 Blattner, 1985, Epidemiology of human T-lymphotropic virus type III and the risk of the acquired immunodeficiency syndrome, Ann Intern Med, 103, 665, 10.7326/0003-4819-103-5-665 Update: Acuired immunodeficiency syndrome (AIDS)–United States. MMWR 33:661–672, 1984 Update: Acquired immunodeficiency syndrome–United States. MMWR 34:245–260, 1985 Results of human T-lymphotropic virus type III test kits reported from blood collection centers–United States, April 22-May 18, 1985. MMWR 34:375–376, 1985 Osterholm, 1985, Screening donated blood and plasma for HTLV-III antibody, Sounding Board, 312, 1185 Sayers, 1986, HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibody to human T-lymphotropic virus type III, Transfusion, 26, 113, 10.1046/j.1537-2995.1986.26186124012.x Holland, 1985, Anti–HTLV-III testing of blood donors: Reproducibility and confirmability of commercial test kits, Transfusion, 25, 395, 10.1046/j.1537-2995.1985.25485273826.x Schüpbach, 1985, Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS, New Engl J Med, 312, 265, 10.1056/NEJM198501313120502 Sandstrom, 1985, Detection of human anti–HTLV-III antibodies by indirect immunofluorescence using fixed cells, Transfusion, 25, 308, 10.1046/j.1537-2995.1985.25485273806.x Martin, 1986, Importance of confirmatory tests after strongly positive HTLV-III screening tests, New Engl J Med, 314, 1577, 10.1056/NEJM198606123142412 Mason, 1985, Alternative sites for screening blood for antibodies to AIDS virus, New Engl J Med, 313, 1157, 10.1056/NEJM198510313131811 Salahuddin, 1984, HTLV-III in symptom free seronegative persons, Lancet, 2, 1418, 10.1016/S0140-6736(84)91619-2 1986, Transfusion associated human T-lymphotropic virus type III/lymphadenopathy associated virus infection from a seronegative donor–Colorado, MMWR, 35, 389 Eckholm E: The New York Blood Bank says 700 might have got AIDS virus. New York Times July l7, 1986, p 1 Martin, 1985, Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy associated virus, J Infect Dis, 1152, 400, 10.1093/infdis/152.2.400 Cohn, 1946, J Am Chern Soc, 68, 459, 10.1021/ja01207a034 Schroeder, 1970, Australia antigen: Distribution during Cohn ethanol fractionation of human plasma, Science, 168, 1462, 10.1126/science.168.3938.1462 Wells, 1986, Inactivation and partition of human T-cell lymphotropic virus, type III, during ethanol fractionation of plasma, Transfusion, 26, 210, 10.1046/j.1537-2995.1986.26286152919.x Berkman, 1986, AIDS and plasma derived products in the USA, 399 Gerety, 1982, Plasma derivatives and viral hepatitis, Transfusion, 22, 347, 10.1046/j.1537-2995.1982.22583017454.x Levy, 1984, Recovery and inactivation of infectious retroviruses from factor VIII concentrates, Lancet, 2, 722, 10.1016/S0140-6736(84)92627-8 McDougal, 1985, Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor, J Clin Invest, 76, 875, 10.1172/JCI112045 Pirofsky, 1982, Individual patient variations in the kinetics of intravenous immune globulin administration, J Clin Immunol, 2, 7, 10.1007/BF00918361 Pirofsky, 1984, Intravenous immune globulin therapy in hypogammaglobulinemia, Am J Med, 76, 53, 10.1016/0002-9343(84)90320-6 Warrier, 1984, Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenia purpura in children, Am J Med, 76, 193, 10.1016/0002-9343(84)90341-3 Oral, 1984, Intravenous gamma globulin in the treatment of chronic idiopathic thrombocytopenic purpura in adults, Am J Med, 76, 187, 10.1016/0002-9343(84)90340-1 Carroll, 1984, Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura, Am J Med, 76, 181, 10.1016/0002-9343(84)90339-5 Shirani, 1984, Replacement therapy with modified immunoglobulin G in bum patients: preliminary kinetic studies, Am J Med, 76, 175, 10.1016/0002-9343(84)90338-3 Besa, 1984, Use of intravenous immunoglobulin in chronic lymphocytic leukemia, Am J Med, 76, 209, 10.1016/0002-9343(84)90344-9 Lane, 1983, Non-A, non-B hepatitis from intravenous immunoglobulin, Lancet, 2, 974, 10.1016/S0140-6736(83)90496-8 Communicable Disease Center, personal communication Tedder, 1985, Safety of immunoglobulin preparation containing anti-HTLV-III, Lancet, 1, 815, 10.1016/S0140-6736(85)91468-0 1986, Safety to therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy associated virus infection, MMWR, 35, 231 Webster, 1986, Isolation of retroviruses from two patients with “common variable” hypogammaglobulinaemia, Lancet, 1, 581, 10.1016/S0140-6736(86)92809-6 Bremard-Oury, 1986, Screening for antibodies to LAV/HTLV-III in recipients of immunoglobulin preparations, Lancet, 1, 1090, 10.1016/S0140-6736(86)91351-6 Prince, 1986, Effect of Cohn fractionation conditions on infectivity of the AIDS virus, New Engl J Med, 314, 386, 10.1056/NEJM198602063140614 Hein, 1986, Elimination of human immunodeficiency virus from immunoglobulin preparations, Lancet, 1, 1217, 10.1016/S0140-6736(86)91202-X Seeff, 1978, Type B hepatitis after needle stick exposure: prevention with hepatitis B immune globulin, Ann Intern Med, 88, 285, 10.7326/0003-4819-88-3-285 Werner, 1982, Accidental hepatitis-B surface-antigen-positive inoculations, Ann Intern Med, 97, 367, 10.7326/0003-4819-97-3-367 Skinhoj, 1981, Epidemiological aspects of viral hepatitis A and B infections, Dan Med Bull, 28, l77 Norkrans, 1978, Clinical epidemiological and prognostic aspects of hepatitis A,B and non-A, non-B, Scand J Infect Dis, l7, 1, 10.3109/inf.1978.10.suppl-17.01 Hoofnagle, 1981, Type B hepatitis: Virology, serology and clinical course, Semin Liver Dis, 1, 102, 10.1055/s-2008-1063925 1985, Suboptimal response to hepatitis B vaccine given by injection into the buttock, MMWR, 34, 105 Dienstag, 1984, Hepatitis B vaccine care personnel: Safety, immunogenicity, and indicators of efficacy, Ann Intern Med, 101, 34, 10.7326/0003-4819-101-1-34 1984, Hepatitis B vaccine: Evidence confirming lack of AIDS transmission, MMWR, 33, 685 Francis, 1986, The safety of the hepatitis B vaccine, JAMA, 256, 869, 10.1001/jama.256.7.869 Merck, Sharpe and Dohme: personal communication, June 1983 Hadler, 1986, Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men, New Engl J Med, 315, 209, 10.1056/NEJM198607243150401 Scolnick, 1984, Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA, JAMA, 251, 2812, 10.1001/jama.251.21.2812 Zajac, 1986, Overview of clinical studies with hepatitis B vaccine made by recombinant DNA, J Infect, 13, 39, 10.1016/S0163-4453(86)92668-X Pneumocystis carinii pneumonia among persons with hemophilia. Morb Mort Wkly Rep 31:365–367, 1982 Lederman, 1983, Impaired cell-mediated immunity in patients with classic hemophilia, Med Int, 308, 79 Menitove, 1983, T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates, Med Int, 308, 83 Goldsmith, 1983, T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia, Ann Intern Med, 98, 294, 10.7326/0003-4819-98-3-294 Desforges, 1983, AIDS and preventive treatment in hemophilia, New Engl J Med, 308, 94, 10.1056/NEJM198301133080209 O Ratnoff: personal communication, June 1984 Djerset, 1984, Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate, Blood, 64, 715, 10.1182/blood.V64.3.715.715 Update: Acquired immunodeficiency syndrome (AIDS) in persons with hemophilia. MMWR 33:589–591, 1985 Goedert, 1985, Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate, Blood, 65, 492, 10.1182/blood.V65.2.492.492 Brettler, 1987, Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B, Blood, 70, 276, 10.1182/blood.V70.1.276.276 White, 1986, HTLV-III seroconversion association with heat-treated factor VIII concentrate, Lancet, 1, 611, 10.1016/S0140-6736(86)92828-X van den Berg, 1986, Seroconversion to HTLV-III in haemophiliacs given heattreated factor VIII concentrates, Lancet, 1, 803, 10.1016/S0140-6736(86)91814-3 Rousell, 1986, Heat treatment of factor VIII concentrate, Lancet, 1, 1389, 10.1016/S0140-6736(86)91705-8 Spire, 1984, Inactivation of lymphadenopathy associated virus by chemical disinfectants, Lancet, 2, 899, 10.1016/S0140-6736(84)90657-3 Levine, 1985, The acquired immunodeficiency syndrome in persons with hemophilia, Ann Intern Med, 103, 723, 10.7326/0003-4819-103-5-723 Hyland Therapeutic, Travenol Laboratories: Hemofil T antihemophilic factor (human). Glendale, CA, 1983 Colombo, 1985, Transmission of non-A, non-B hepatitis by heat treated factor VIII concentrate, Lancet, 2, 1, 10.1016/S0140-6736(85)90055-8 Bird, 1985, Haemophilia and AIDS, Lancet, I, 162, 10.1016/S0140-6736(85)91929-4 Bloom, 1985, Haemophilia and AIDS, Lancet, 1, 336, 10.1016/S0140-6736(85)91103-1 Barrowcliffe, 1986, Factor VIII degradation products in heated concentrates, Lancet, 1, 1448, 10.1016/S0140-6736(86)91599-0 Medical and Scientific Advisory Council, National Hemophilia Foundation: Recommendations concerning AIDS and the treatment of hemophilia. New York, National Hemophilia Foundation, 1985 Kasper, 1984, Cryoprecipible, all in the family?, JAMA, 252, 2755, 10.1001/jama.252.19.2755b Richardson, 1985, Desmopressin, Ann Intern Med, 103, 228, 10.7326/0003-4819-103-2-228 de la Fuente, 1985, Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin, Ann Intern Med, 103, 6, 10.7326/0003-4819-103-1-6 Mannucci, 1977, l-deamino-8-d-arginine vasopressin: A new pharmacologic approach to the management of hemophilia and von Willebrand's disease, Lancet, 1, 869, 10.1016/S0140-6736(77)91197-7 Mannucci, 1983, Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia, New Engl J Med, 308, 8, 10.1056/NEJM198301063080102 Mannucci, 1986, Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time, Blood, 67, 1148, 10.1182/blood.V67.4.1148.bloodjournal6741148 Lusher, 1985 Salzman, 1986, Treatment with desmopressin acetate to reduce blood loss after cardiac surgery, New Engl J Med, 314, 1402, 10.1056/NEJM198605293142202 Update: acquired immunodeficiency syndrome–United States. MMWR 35:17–21, 1986. Ward, 1987, Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome, Ann Intern Med, 106, 61, 10.7326/0003-4819-106-1-61 Anderson, 1986, Transfusion acquired HTLV-III/LAV infection among immunocompromised hosts, Ann Intern Med, 105, 519, 10.7326/0003-4819-105-4-519 Kroegel, 1987, Routes of HIV-2 transmission in western Europe, Lancet, 1, 1150, 10.1016/S0140-6736(87)91712-0 Courouce, 1987, HIV-2 in blood donors and in different risk groups in France, Lancet, 1, 1151, 10.1016/S0140-6736(87)91713-2